Byrne S, Beatty S
Department of Ophthalmology, Royal Victoria Infirmary, Newcastle-upon-Tyne, UK.
Ir J Med Sci. 2003 Oct-Dec;172(4):185-90. doi: 10.1007/BF02915287.
Age-related macular degeneration (AMD) is the leading cause of visual impairment and blindness in the Western World in those aged 65 and older. At present, several treatment modalities are utilised and several more are undergoing investigation in an attempt to retard the occurrence and progression of this devastating condition.
To provide the non-ophthalmologist with an understanding of the current treatment options available to patients suffering from all variants of AMD.
Medline and Embase search.
Several treatment modalities have been investigated and utilised in the treatment of all variants of this condition. While promising results have been reported, no treatment is ideal.
While no curative treatment for this condition currently exists, early recognition and treatment, if indicated, have been shown to reduce the risk of severe vision loss in patients with this condition.
年龄相关性黄斑变性（AMD）是西方世界65岁及以上人群视力损害和失明的主要原因。目前，人们采用了多种治疗方式，还有几种正在进行研究，试图延缓这种破坏性疾病的发生和发展。
让非眼科医生了解目前可用于患有各种类型AMD患者的治疗选择。
检索Medline和Embase数据库。
已经对几种治疗方式进行了研究并用于治疗这种疾病的各种类型。虽然报告了一些有前景的结果，但没有一种治疗方法是理想的。
虽然目前尚无治愈这种疾病的方法，但早期识别并在有指征时进行治疗已被证明可降低患有这种疾病的患者严重视力丧失的风险。
